1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Convulsive Generalized Seizure Disorder in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Endo, S; Hirashima, Y; Ikeda, H; Karasawa, K; Kurimoto, M; Sato, N; Setaka, M; Takaku, A; Yokoyama, K | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Convulsive Generalized Seizure Disorder
Article | Year |
---|---|
Deficient platelet-activating factor and related enzymes in hemimegalencephaly.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Atrophy; Epilepsy, Generalized; Female; Humans; Infant; Magnetic Resonance Imaging; Occipital Lobe; Phospholipases A; Platelet Activating Factor; Psychosurgery; Rabbits; Recurrence; Reoperation; Transferases (Other Substituted Phosphate Groups) | 1999 |